NASDAQ · ENGNHealthcareBiotechnology

enGene Therapeutics dividends & splits

$1.95−1.02%
Close Sep 29, 2026 · split-adjusted
YieldNoneNo regular dividend in the last year
Latest dividend$0.1263Ex-date Aug 3, 2015
FrequencyMonthly
2015 total$0.88-44.4% vs 2014

Dividends per share by year

Payment history

Ex-datePaidAmountType
Aug 3, 2015Aug 7, 2015$0.1263Regular
Jul 1, 2015Jul 8, 2015$0.1251Regular
Jun 1, 2015Jun 5, 2015$0.1251unknown
May 1, 2015May 7, 2015$0.1219Regular
Apr 1, 2015Apr 8, 2015$0.1294Regular
Mar 2, 2015Mar 6, 2015$0.1235Regular
Feb 2, 2015Feb 6, 2015$0.128Regular
Dec 24, 2014Dec 31, 2014$0.1312Regular
Dec 1, 2014Dec 5, 2014$0.1417Regular
Nov 3, 2014Nov 7, 2014$0.1541Regular
Oct 1, 2014Oct 7, 2014$0.1541Regular
Sep 2, 2014Sep 8, 2014$0.132Regular
Aug 1, 2014Aug 7, 2014$0.1209Regular
Jul 1, 2014Jul 8, 2014$0.1273Regular
Jun 2, 2014Jun 6, 2014$0.127Regular
May 1, 2014May 7, 2014$0.129Regular
Apr 1, 2014Apr 7, 2014$0.1178Regular
Mar 3, 2014Mar 7, 2014$0.1228Regular
Feb 3, 2014Feb 7, 2014$0.1229Regular
Dec 26, 2013Jan 2, 2014$0.1225Regular
Dec 2, 2013Dec 6, 2013$0.119Regular
Nov 1, 2013Nov 7, 2013$0.1168Regular
Oct 1, 2013Oct 7, 2013$0.1201Regular
Sep 3, 2013Sep 9, 2013$0.1191Regular
Aug 1, 2013Aug 7, 2013$0.1156Regular
Jul 1, 2013Jul 8, 2013$0.1135Regular
Jun 3, 2013Jun 7, 2013$0.1093Regular
May 1, 2013May 7, 2013$0.115Regular
Apr 1, 2013Apr 5, 2013$0.1145Regular
Mar 1, 2013Mar 7, 2013$0.1211Regular
Feb 1, 2013Feb 7, 2013$0.1144Regular
Dec 26, 2012Jan 2, 2013$0.1093Regular
Dec 3, 2012Dec 7, 2012$0.114Regular
Nov 1, 2012Nov 7, 2012$0.1158Regular
Oct 1, 2012Oct 5, 2012$0.1179Regular
Sep 4, 2012Sep 10, 2012$0.116Regular
Aug 1, 2012Aug 7, 2012$0.1162Regular
Jul 2, 2012Jul 9, 2012$0.1093unknown
Jun 1, 2012Jun 7, 2012$0.1077unknown
May 1, 2012May 7, 2012$0.1161unknown
Apr 2, 2012Apr 9, 2012$0.1746unknown

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology